Table 1 Baseline characteristics of surgical patients with or without the use of TXA during surgery
From: Use of Tranexamic Acid (TXA) on reducing blood loss during scoliosis surgery in Chinese adolescents
| Demographics | Tranexamic acid | P | |
|---|---|---|---|
| TXA (N = 55) | Control (N = 35) | ||
| Age | |||
| Mean ± SD (Range) | 15.16 ± 2.61 (10–21) | 15.31 ± 2.97 (11–23) | 0.80 |
| ≥ 12 | 11 (20.0) | 4 (11.4) | 0.32 |
| 13–14 | 13 (23.6) | 15 (42.9) | |
| 15–16 | 11 (20.0) | 4 (11.4) | |
| 17–18 | 15 (27.3) | 8 (22.9) | |
| ≥ 19 | 5 (9.1) | 4 (11.4) | |
| Max major curve (Pre-op) | 73.42 ± 11.75 | 63.23 ± 17.20 | <0.01 |
| Body weight (kg) | |||
| Pre-op | 45.25 ± 8.96 | 42.88 ± 7.76 | 0.20 |
| Post-op | 44.49 ± 8.14 | 43.39 ± 8.88 | 0.65 |
| Armspan (cm) | |||
| Pre-op | 157.04 ± 8.99 | 158.32 ± 9.83 | 0.54 |
| Post-op | 156.04 ± 9.40 | 158.79 ± 9.23 | 0.35 |
| Body height (cm) | |||
| Pre-op | 154.01 ± 9.33 | 155.36 ± 7.70 | 0.48 |
| Post-op | 156.83 ± 9.88 | 157.76 ± 8.82 | 0.73 |
| BMI (kg/m2) | |||
| Pre-op | 19.03 ± 3.53 | 17.76 ± 3.00 | 0.08 |
| Post-op | 18.07 ± 2.77 | 17.47 ± 3.28 | 0.48 |
| Number of segments fused | 13.51 ± 1.62 | 12.14 ± 2.79 | 0.01 |
| Number of pedicle screws inserted | 16.15 ± 2.17 | 16.29 ± 4.34 | 0.87 |
| Bone graft | |||
| Allograft | 1 (2.0) | 8 (28.6) | <0.01 |
| Autograft/Both | 49 (98.0) | 20 (71.4) | |
| Unknown | 5 | 7 | |
| Length of surgery | 436.71 ± 122.53 | 502.14 ± 85.81 | <0.01 |